The clinical-stage anti-TFRC antibody PPMX-T003 suppresses #ColorectalCancer growth in a patient-derived #Xenograft and reduces liver metastatic seeding and colonization, supporting TFRC-targeted therapy for #Metastatic cancer.
#OpenAccess: https://t.co/N9WSOS44gn